Intezyne Technologies Granted Orphan Drug Designation for IT-139 in Pancreatic Cancer
Intezyne Technologies Granted Orphan Drug Designation for IT-139 in Pancreatic Cancer
Comments are closed.
Intezyne Technologies Granted Orphan Drug Designation for IT-139 in Pancreatic Cancer